Search
Close this search box.

Category: Press Releases

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – APLT

NEW YORK, Jan. 15, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”), of the important February 18, 2025 lead plaintiff deadline. SO WHAT: If you purchased Applied Therapeutics […]

Read More

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – APLT

NEW YORK, Jan. 15, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”), of the important February 18, 2025 lead plaintiff deadline. SO WHAT: If you purchased Applied Therapeutics […]

Read More

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PCRX

NEW YORK, Jan. 15, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Pacira BioSciences, Inc. (NASDAQ: PCRX) between August 2, 2023 and August 8, 2024, both dates inclusive (the “Class Period”). A lawsuit has already […]

Read More

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PCRX

NEW YORK, Jan. 15, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Pacira BioSciences, Inc. (NASDAQ: PCRX) between August 2, 2023 and August 8, 2024, both dates inclusive (the “Class Period”). A lawsuit has already […]

Read More

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PCRX

NEW YORK, Jan. 15, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Pacira BioSciences, Inc. (NASDAQ: PCRX) between August 2, 2023 and August 8, 2024, both dates inclusive (the “Class Period”). A lawsuit has already […]

Read More

CUBI IMPORTANT DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Customers Bancorp, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – CUBI

NEW YORK, Jan. 15, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Customers Bancorp, Inc. (NYSE: CUBI) between March 1, 2024 and August 8, 2024, both dates inclusive (the “Class Period”), of the January 31, 2025 lead plaintiff deadline in the securities class action first filed by […]

Read More

CUBI IMPORTANT DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Customers Bancorp, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – CUBI

NEW YORK, Jan. 15, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Customers Bancorp, Inc. (NYSE: CUBI) between March 1, 2024 and August 8, 2024, both dates inclusive (the “Class Period”), of the January 31, 2025 lead plaintiff deadline in the securities class action first filed by […]

Read More